Validity of Cardiovascular Risk Prediction Models in Kidney Transplant Recipients

by Holly Mansell, Samuel Alan Stewart, Ahmed Shoker
Published 2014-01-01

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

by Kerry Mansell, Hishaam Bhimji, Dean Eurich, Holly Mansell
Published 2019-12-01

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

by Kerry Mansell, Hishaam Bhimji, Dean Eurich, Holly Mansell
Published 2019-11-01

Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level

by Ahmed Zahran, Ahmed Attia, Holly Mansell, Ahmed Shoker
Published 2018-09-01

Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events.

by Holly Mansell, Mahmoud Soliman, Hamdi Elmoselhi, Ahmed Shoker
Published 2015-01-01

Circulating chemokine ligand levels before and after successful kidney transplantation

by Hamdi Elmoselhi, Holly Mansell, Mahmoud Soliman, Ahmed Shoker
Published 2016-10-01

Readability and Suitability of COPD Consumer Information

by Kathryn Fullmann, David F. Blackburn, Mark E. Fenton, Holly Mansell
Published 2017-01-01

The Saskatchewan Medication Assessment Program for Patients With Renal Failure: A Qualitative Study to Understand Health Care Provider Perspectives

by Anan Ahmed, David F. Blackburn, Charity Evans, Nicola Rosaasen, Holly Mansell
Published 2020-10-01

A Randomized Controlled Trial of a Pretransplant Educational Intervention in Kidney Patients

by Holly Mansell, PharmD, Nicola Rosaasen, BSP, Jenny Wichart, BScPharm, Rahul Mainra, MD, Ahmed Shoker, MD, Michele Hoffert, BSW, David F. Blackburn, PharmD, Juxin Liu, PhD, Brianna Groot, BA, Paraag Trivedi, BSP, Errin Willenborg, BSA, Maithiri Amararajan, BSc, Huokai Wu, BSc, Annshirley Afful, PhD
Published 2021-10-01